10.1002/cbic.201700080
ChemBioChem
FULL PAPER
General methods for organic synthesis: All reagents were of
commercial grade and used as received unless stated otherwise.
Reactions were performed at room temperature unless stated otherwise.
Molecular sieves (4Å) were flame dried before use. Flash column
chromatography was performed on silica gel (40-63 µm). 1H and 13C
NMR spectra were recorded on a Bruker AV 600, Bruker AV 400 or a
Bruker DPX 400 spectrometer in D2O or CD3OD. Chemical shifts (δ) are
given in ppm relative to the solvent residual signals. Coupling constants
(J) are given in Hz. All given 13C spectra are proton decoupled.
Compound names are given using the standard iminosugar
nomenclature numbering.
evaporated with dry toluene, put under argon and suspended in dry
MeOH (10 ml). The suspension was cooled to 0 °C before addition of
distilled triethylamine (1.0 ml, 7.2 mmol) and the resulting clear solution
was stirred overnight. The reaction mixture was concentrated under
reduced pressure yielding the methyl ester as a white semi-crystalline
solid. The residue was put under argon, dissolved in dry EtOH
(molsieves, 10 ml) and cooled to 0°C. Sodium borohydride (709 mg, 19
mmol) was added and the suspension was stirred overnight. Dry MeOH
(20 ml) was added before the mixture was filtered, concentrated under
reduced pressure and co-evaporated with 1M HCl in MeOH (3x, 10 ml).
The residue was purified by column chromatography (1:1 EtOAc/EtOH "
100% EtOH) yielding a pure sample of DMJ (2) in 29% yield (105 mg,
0.50 mmol). 1H NMR (399 MHz, D2O): δ 3.99 (1H, dt, J = 2.9, 1.6 Hz, C-
3), 3.76 (1H, dd, J = 12.5, 3.9 Hz, C-7), 3.71 (1H, dd, J = 12.5, 5.5 Hz, C-
7a), 3.60 (1H, t, J = 9.7 Hz, C-5), 3.53 (1H, dd, J = 9.6, 3.1 Hz, C-4), 3.03
(1H, dd, J = 14.2, 2.8 Hz, C-2a), 2.80 (1H, dd, J = 14.2, 1.5 Hz, C-2b),
2.57 (1H, ddd, J = 9.7, 4.9, 3.4 Hz, C-6). 13C NMR (101 MHz, MeOD): δ
74.4 (C-4), 67.6 (C-5), 67.5 (C-3), 62.4 (C-6), 59.6 (C-7), 48.9 (C-2).
[α]20D: -14.0° (c = 0.5, MeOH).
2,6-dibromo-2,6-dideoxy-D-mannono-1,4-lactone (7): Calcium D-
gluconate monohydrate 5 (126 g, 280 mmol) was put under an argon
atmosphere before being dissolved in 33% HBr in acetic acid (500 ml,
3.0 mol). The reaction mixture was stirred for 18 hours to form acetylated
6. MeOH (1 l) was added and the mixture was refluxed for 2 hours. After
refluxing the mixture was concentrated to half the volume under reduced
pressure before adding another 500 ml of MeOH. The reaction was left to
stir overnight after which the mixture was concentrated resulting in a
slightly oily residue. This was co-evaporated with 100 ml of MeOH and
three times with H2O. The residue was extracted with diethyl ether (4 x
100 ml), the organic layers were combined, dried with MgSO4, filtered
and concentrated under vacuum yielding a yellow oily residue. This was
crystallized from CHCl3 / H2O to yield a white crystalline solid (44 g, 146
mmol, 26% yield). 1H NMR (400 MHz, D2O): δ 5.20 (1H, d, J = 4.5 Hz,
C-2), 4.64 (2H, m, C-4, C-3), 4.19 (1H, m, C-5), 3.77 (1H, dd, J = 11.4,
2,4 Hz, C-6a), 3.65 (1H, dd, J = 11.4, 4.9 Hz, C-6b). 13C NMR (101 MHz,
D2O): δ 174.0 (C-1), 81.6 (C-4), 69.1 (C-3), 66.2 (C-5), 47.6 (C-2), 36.6
(C-6). Melting point: 130 °C. [α]20D: +58,6° (c = 1, MeOH).
Methyl 2,6-dideoxy-2,6-imino-D-mannonate hydrochloride (3): 2-
amino-6-bromo-2,6-dideoxy-D-mannono-1,4-lactone hydrochloride (7,
0.60 g, 2.2 mmol), was co-evaporated thrice with dry toluene, put under
argon and suspended in dry MeOH (12 ml). The suspension was cooled
to 0 °C before addition of distilled triethylamine (1.2 ml, 8.7 mmol) and
the resulting clear solution was stirred overnight. The reaction mixture
was concentrated under reduced pressure before being taken up in
acetonitrile (15 ml) charged with 1,1,1,3,3,3-hexamethyldisilazane (2.5 ml,
12 mmol) and copper sulphate pentahydrate (cat.). After 1 hour, the
reaction mixture was concentrated and a fraction of 234 mg (0.57 mmol)
was purified by column chromatography (1-2.5% 1,4-dioxane/DCM) to
give 162 mg (0.40 mmol) of the per-TMSylated compound. The protected
product was put under argon, dissolved in MeOH (8 ml) and acetyl
chloride (1 eq) added to generate HCl in situ. The mixture was stirred for
0.5 hour, after which the compound was concentrated and coevaporated
with MeOH yielding the title compound (98 mg, 0.40 mmol, 70% over 2
steps). 1H NMR (400 MHz, MeOD) δ 4.40 (dd, J = 5.3, 4.8 Hz, 1H, C-5),
4.17 (ddd, J = 9.5, 4.1, 2.8 Hz, 1H, C-3), 4.09 (d, J = 4.4 Hz, 1H, C-6),
3.86 (dd, J = 5.6, 2.7 Hz, 1H, C-4), 3.82 (s, 3H, OCH3), 3.44 (dd, J =
12.2, 9.6 Hz, 1H, C-2a), 3.13 (dd, J = 12.2, 4.2 Hz, 1H, C-2b). 13C NMR
(101 MHz, MeOD) δ 168.1 (C-7), 71.1 (C-4), 69.9 (C-5), 64.2 (C-3), 58.8
(C-6), 53.4 (OCH3), 43.5 (C-2). [α]20D: +31.8 (c = 1, MeOH).
2-amino-6-bromo-2,6-dideoxy-D-mannono-1,4-lactone hydrochloride
(8): 2,6-Dibromo-2,6-dideoxy-D-mannono-1,4-lactone (6, 5.0 g, 16.5
mmol) was put under argon and dissolved in dry acetone (MgSO4, 100
ml). Sodium azide (15.0 g, 231 mmol) was added and the suspension
was refluxed for 20 hours. The mixture was filtrated and the filtrate
concentrated under reduced pressure. The residue was dissolved in H2O
(50 ml) and extracted with diethyl ether (5 x 100 ml), the organic layers
were combined, dried over MgSO4, filtered and concentrated under
reduced pressure to give a brown oil which was identified as the 2-azido
compound but included some of its diastereoisomer. 1H NMR (400 MHz,
D2O): δ 4.68 (1H, dd, J = 4.5, 3.3 Hz, C-3), 4.56 (1H, d, J = 4.6 Hz, C-2),
4.46 (1H, dd, J = 9.2, 2.7 Hz, C-4), 4.09 (1H, m, C-5), 3.69 (1H, dd, J =
11.4, 2.7 Hz, C-6a), 3.56 (1H, dd, J = 11.5, 4.9 Hz, C-6b). 13C NMR (101
MHz, D2O): δ 174.1 (C-1), 81.0 (C-4), 69.6, 65.7 (C-3, C-5), 62.3 (C-2),
36.6 (C-6). The crude compound (16.5 mmol) was put under argon and
dissolved in MeOH (100 ml). Palladium on activated carbon (10%, 300
mg, 0.3 mmol) and HCl (37% in H2O, 10 ml, 121 mmol) were added and
the suspension charged with hydrogen atmosphere. The reaction mixture
was stirred for 22 hours after which the catalyst was filtered off over a
Whatman microfilter. The filtrate was concentrated under reduced
pressure and co-evaporated once with HCl (37% in H2O, 60 ml), thrice
with toluene (60 ml) and once with CHCl3 (50 ml). Crystallization from
Sodium 2,6-dideoxy-2,6-imino-D-mannonate (4): Methyl 2,6-dideoxy-
2,6-imino-D-mannonate hydrochloride (3, 24 mg, 0.10 mmol), was
dissolved in H2O (0.5 ml). A sodium hydroxide solution (1M aq., 170 μl,
0.17 mmol) was added and the mixture stirred for 2 hours. The mixture
was concentrated under reduced pressure yielding the title compound,
pure but with added sodium hydroxide. 1H NMR (400 MHz, D2O): δ 4.01
(1H, m, C-3), 3.71 (1H, t, J = 9.7 Hz, C-5), 3.60 (1H, dd, J = 9.6, 3.2 Hz,
C-4), 3.01 (1H, dd, J = 14.6, 2.7 Hz, C-2a), 2.95 (1H, d, J = 9.8 Hz, C-6),
2.75 (1H, dd, J = 14.6, 1.6 Hz, C-2b). 13C NMR (101 MHz, D2O): δ 178.4
(C-7), 74.1 (C-4), 70.6 (C-5), 69.1 (C-3), 65.2 (C-6), 47.9 (C-2). [α]20D: -
7.2 (c = 1, MeOH).
EtOH
yielded
2-amino-6-bromo-2,6-dideoxy-D-mannono-1,4-lactone
hydrochloride (8) as white crystals (2.6 g, 9.2 mmol, 55% over two steps).
1H NMR (400 MHz, D2O): δ 4.83 (1H, dd, J = 4.8, 2.8 Hz, C-3), 4.63 (1H,
dd, J = 9.2, 2.7 Hz, C-4), 4.59 (1H, d, J = 4.9 Hz, C-2), 4.20 (1H, m, C-5),
3.77 (1H, dd, J = 11.5, 2.6 Hz, C-6a), 3.65 (1H, dd, J = 11.4, 5.0 Hz, C-
6b). 13C NMR (101 MHz, D2O): δ 172.1 (C-1), 78.9 (C-4), 64.1 (C-3), 62.9
2,6-dideoxy-2,6-imino-D-mannonic amide (5): 2-amino-6-bromo-2,6-
dideoxy-D-mannono-1,4-lactone hydrochloride (7, 500 mg, 1.8 mmol),
was co-evaporated thrice with dry toluene, put under argon and
suspended in dry MeOH (10 ml). The suspension was cooled to 0 °C
before addition of distilled triethylamine (1.0 ml, 7.2 mmol) and the
resulting clear solution was stirred overnight. The reaction mixture was
concentrated under reduced pressure yielding the methyl ester as a
white semi-crystalline solid. The residue was dissolved in 6M ammonia in
MeOH (10 ml, 60 mmol) and was stirred overnight. The reaction mixture
(C-5), 50.2 (C-2), 33.7 (C-6). Melting point: 207 °C (decomposed). [α]20
+41.6° (c = 1, MeOH).
:
D
1-Deoxymannojirimycin (2): 2-amino-6-bromo-2,6-dideoxy-D-mannono-
1,4-lactone hydrochloride (7, 501 mg, 1.8 mmol), was three times co-
For internal use, please do not delete. Submitted_Manuscript
This article is protected by copyright. All rights reserved.